ALNYLAM PHARMACEUTICALS, INC. Quick Ratio in % from Q2 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
The acid-test ratio, also called the quick ratio, is a metric used to see if a company is positioned to sell assets within 90 days to meet immediate expenses.
Summary
Alnylam Pharmaceuticals, Inc. quarterly Quick Ratio history and growth rate from Q2 2019 to Q3 2025.
  • Alnylam Pharmaceuticals, Inc. Quick Ratio for the quarter ending September 30, 2025 was 5.69 %, a 30.6% decline year-over-year.
Quick Ratio, Quarterly (%)
Quick Ratio, YoY Quarterly Growth (%)

ALNYLAM PHARMACEUTICALS, INC. Quarterly Quick Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 5.69 -2.51 -30.6% Sep 30, 2025
Q2 2025 6.1 -3.17 -34.2% Jun 30, 2025
Q1 2025 6.7 -3.7 -35.6% Mar 31, 2025
Q4 2024 7.55 -4.8 -38.9% Dec 31, 2024
Q3 2024 8.2 -6.18 -43% Sep 30, 2024
Q2 2024 9.27 -6.61 -41.6% Jun 30, 2024
Q1 2024 10.4 -5.8 -35.8% Mar 31, 2024
Q4 2023 12.4 -2.34 -15.9% Dec 31, 2023
Q3 2023 14.4 +0.86 +6.36% Sep 30, 2023
Q2 2023 15.9 +2.19 +16% Jun 30, 2023
Q1 2023 16.2 +2.13 +15.1% Mar 31, 2023
Q4 2022 14.7 +0.15 +1.03% Dec 31, 2022
Q3 2022 13.5 -1.24 -8.4% Sep 30, 2022
Q2 2022 13.7 -0.52 -3.66% Jun 30, 2022
Q1 2022 14.1 -1.02 -6.76% Mar 31, 2022
Q4 2021 14.5 -1.55 -9.63% Dec 31, 2021
Q3 2021 14.8 -2.53 -14.6% Sep 30, 2021
Q2 2021 14.2 -3.76 -20.9% Jun 30, 2021
Q1 2021 15.1 -0.92 -5.75% Mar 31, 2021
Q4 2020 16.1 +0.59 +3.8% Dec 31, 2020
Q3 2020 17.3 +2.32 +15.5% Sep 30, 2020
Q2 2020 18 +4.13 +29.9% Jun 30, 2020
Q1 2020 16 Mar 31, 2020
Q4 2019 15.5 Dec 31, 2019
Q3 2019 15 Sep 30, 2019
Q2 2019 13.8 Jun 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.